Projects per year
Personal profile
Education
-
2013-2019 Ph.D, School of Pharmacy, Taipei Medical University, Taipei, Taiwan
-
2004-2006 M.S. in Clinical Pharmacy, National Cheng Kung University, Tainan, Taiwan
-
2000-2004 B.S. in Pharmacy, National Taiwan University, Taipei, Taiwan
Experience
- 2025- Associate professor, School of Pharmacy, Taipei, Medical University, Taipei, Taiwan
- 2023-2025 Assistant professor, School of Pharmacy, Taipei, Medical University, Taipei, Taiwan
- 2020-2023 Adjunct assistant professor, School of Pharmacy, Taipei, Medical University, Taipei, Taiwan
- 2019 Oncology training in National Cancer Centre Singapore
- 2017- Oncology pharmacist, Wanfang Hospital
- 2016- Board Certified Oncology Pharmacist, USA
- 2015 Oncology training in University of Illinois at Chicago, USA
- 2013-2020 Adjunct instructor, School of Pharmacy, Taipei, Medical University, Taipei, Taiwan
- 2008- Pharmacist, Department of Pharmacy, Wanfang Hospital
Research Interests
-
Clinical pharmacy
-
Cancer pharmacotherapy
-
Pharmacogenomic
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
- 6 Similar Profiles
Collaborations and top research areas from the last five years
-
開發具成本效益與公平性之胺碘酮誘發甲狀腺毒症與功能低下症之風險分層預測模型
Kuo, C.-N. (PI)
7/1/26 → 2/28/27
Project: A - Government Institution › b - National Science and Technology Council
-
Impacts of the Response to Immune Checkpoint Inhibitors in Cancer Therapy: from Clinical Use to Gene Analysis
Kuo, C.-N. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
新聘教師研究補助
Kuo, C.-N. (PI)
1/15/24 → 1/14/25
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
Using Genomic Database to Explore the Treatment Target of Pancreatic Cancer and Possible Drugs
Kuo, C.-N. (PI)
8/1/20 → 12/31/21
Project: A - Government Institution › b - National Science and Technology Council
-
Artificial intelligence for translational personalized neoantigen cancer vaccine development
Wei, C. Y., Lin, H. C., Wu, C. J., Kuo, C. N., Chang, C. M., Chou, W. H., Chou, S. P., Feng, S. H., Huang, W. C., Jiang, S., Fairfax, B. P., Lee, K. Y. & Chang, W. C., Dec 2026, In: Journal of Biomedical Science. 33, 1, 87.Research output: Contribution to journal › Review article › peer-review
Open Access -
Cumulative Dose of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Cohort Study
Kuo, Y. H., Kuo, C. N., Chang, C. L. & Ko, Y., Jul 2025, In: Journal of Gastroenterology and Hepatology (Australia). 40, 7, p. 1745-1753 9 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Effectiveness and Safety of Reduced and Standard Initial Doses of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study in Taiwan
Kuo, Y. H., Kuo, C. N., Chang, C. L. & Ko, Y., Nov 2025, In: Pharmacoepidemiology and Drug Safety. 34, 11, e70221.Research output: Contribution to journal › Article › peer-review
-
Effectiveness and Safety of Regorafenib and TAS-102 in Patients with Metastatic Colorectal Cancer: A Nationwide Population-Based Study in Taiwan
Chang, Y. W., Kuo, C. N., Chang, C. L., Hsu, J. C. & Ko, Y., Jul 2025, In: Cancer Research and Treatment. 57, 3, p. 830-839 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Evaluating the cost-effectiveness of atezolizumab-bevacizumab in advanced hepatocellular carcinoma: Insights from Taiwan
Chang, T. W., Chang, W. C., Chou, W. H., Chang, W. P. & Kuo, C. N., 2025, In: Journal of Food and Drug Analysis. 33, 2, p. 163-171 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Citations (Scopus)